genia tagger: 73('and', 389)
('cox-2\xe2\x80\x93overexpressing', 4)
('malignant', 5)
('xl', 2)
('ht-29', 36)
('beckman', 2)
('epics', 2)
('carboxylic', 18)
('4b', 4)
('vehicle-treated', 8)
('colon', 68)
('ms\\/ms', 2)
('human', 16)
('using', 70)
('ssa', 259)
('deoxynucleotidyl', 2)
('acid', 26)
('mouse', 11)
('moiety', 21)
('tumor', 192)
('end', 21)
('caspases', 8)
('table', 16)
('nick', 2)
('\xc3\x97', 4)
('terminal', 2)
('3', 127)
('isozyme', 8)
('cell', 157)
('hct116', 9)
('only', 16)
('sw480', 11)
('tunel-positive', 2)
('7', 91)
('dutp', 2)
('\\.', 666)
('cultures', 6)
('fragments', 6)
('apc', 2)
('\\(', 121)
('\\)', 121)
('cytometer\\.', 4)
('topoisomerase', 4)
('apoptotic', 12)
('r120', 8)
('cox\\-2\\.', 8)
('cyclooxygenase', 2)
('cox-1', 90)
('cox-2', 106)
('caspase', 32)
('fig\\.', 68)
('incorporation', 8)
('thymidine', 12)
('line', 19)
('106', 2)
('2', 344)
('radioactive', 2)
('1640', 2)
('xenograft', 9)
('cox', 240)
('cells', 68)
('tunel', 10)
('flow', 4)
('labeling', 2)
('coulter', 4)
('rpmi', 2)
('cyclooxygenases', 1)
('assay\\.', 4)
('2b', 4)
('transferase-mediated', 2)
('model', 44)
('dosing\\.', 2)
('lines', 11)


spacy + metamap: 495('chain', 2)
('ht-29', 36)
('lack', 21)
('resistance', 2)
('llc', 2)
('guava', 4)
('physiological', 4)
('graph', 4)
('body weights', 4)
('nu\\/nu', 6)
('tween', 14)
('suite', 2)
('activities', 16)
('assay', 34)
('apoptosis', 26)
('cyclooxygenase', 2)
('induce', 19)
('difference', 12)
('condition', 8)
('malignant disease', 3)
('entire', 2)
('kits', 2)
('2 hours', 4)
('unit density', 2)
('amine group', 8)
('smaller', 4)
('dna synthesis', 13)
('isozymes', 6)
('guidelines', 2)
('dish', 4)
('rate', 56)
('further', 6)
('caspase activation', 8)
('residue', 2)
('activity levels', 4)
('cell', 157)
('3h', 8)
('malignant cells', 2)
('3c', 4)
('3b', 4)
('increasing', 2)
('arachidonic acid', 2)
('injections', 8)
('proliferation', 4)
('colorectal cancer', 6)
('tumor cell lines', 5)
('atoms', 4)
('thymidin', 12)
('groups', 14)
('acceptor', 2)
('ellipsoid', 2)
('study', 12)
('larger', 2)
('reports', 4)
('example', 8)
('amount', 6)
('published', 4)
('action', 12)
('reagents', 4)
('toxicity', 5)
('studies', 55)
('highly', 8)
('iodine', 2)
('ammonium acetate', 2)
('total', 4)
('experimentation', 2)
('environment', 4)
('use', 45)
('amino acids', 6)
('dna', 29)
('cell proliferation', 2)
('positive', 26)
('two', 6)
('molecular target', 4)
('vehicle', 14)
('oxidative metabolism', 4)
('stage', 8)
('more', 19)
('0\\%', 24)
('dosages', 10)
('apc', 2)
('line', 19)
('colon cancer', 5)
('ovine', 4)
('twice daily', 6)
('anti-inflammatory', 3)
('mg', 57)
('values', 31)
('male', 6)
('root', 4)
('dosage', 31)
('control', 38)
('tap', 2)
('indicated', 2)
('calculation', 4)
('agent', 8)
('sample', 8)
('sphere', 4)
('minimum', 2)
('tunel assay', 2)
('docking', 8)
('discussion', 2)
('feature', 4)
('chemical', 16)
('methanol', 2)
('animal', 8)
('mas', 8)
('atp', 6)
('specifications', 6)
('southern', 2)
('cox-1', 90)
('cox-2', 106)
('blood', 2)
('monitoring', 2)
('data', 10)
('ss', 458)
('derivatives', 11)
('element', 2)
('nsaids', 10)
('representation', 2)
('proton magnetic resonance spectroscopy', 2)
('sulindac sulfone', 4)
('experiments', 2)
('fetal bovine serum', 2)
('filters', 2)
('unfavorable', 4)
('isozyme', 8)
('group', 84)
('ligand', 8)
('fit', 16)
('late', 30)
('fig', 68)
('derivative', 18)
('uptake', 2)
('non', 13)
('combination', 2)
('vitro', 25)
('break', 14)
('dock', 18)
('compound', 12)
('metabolite', 10)
('day', 68)
('structural', 4)
('alex', 2)
('oxygen', 4)
('l-', 5)
('antineoplastic', 4)
('mode', 54)
('2b', 4)
('irinotecan hcl', 2)
('side', 12)
('investigators', 10)
('heavy', 4)
('domain', 2)
('square', 4)
('weight', 50)
('series', 11)
('product', 2)
('mm3', 4)
('intended', 2)
('20\\%', 4)
('viability', 4)
('research', 2)
('increase', 20)
('mediated', 2)
('safety', 3)
('formula', 6)
('induced', 12)
('induction', 9)
('viable', 2)
('molecular modeling', 8)
('solvent', 4)
('caspase', 32)
('standard', 4)
('formation', 4)
('propidium', 4)
('benefits', 8)
('xenograft', 9)
('days', 32)
('cell culture', 4)
('levels', 33)
('tumor growth', 25)
('first', 4)
('size', 16)
('major', 8)
('xl', 2)
('number', 16)
('body weight', 16)
('electronic', 2)
('maximum tolerated dose', 2)
('given', 10)
('t test', 10)
('top', 8)
('approximately', 8)
('sulfone', 18)
('intermediate', 2)
('observations', 6)
('chemotherapy', 5)
('percentage', 10)
('molecular', 12)
('structures', 14)
('final', 6)
('apoptotic', 12)
('ncr', 28)
('continuous', 8)
('antitumor', 17)
('part', 4)
('familial adenomatous polyposis', 4)
('institution', 4)
('in vitro', 23)
('\\%\\ inhibition', 2)
('target', 8)
('fold', 8)
('preparation', 2)
('compensation', 2)
('chemically induced', 2)
('h 2', 4)
('treated', 22)
('time period', 8)
('bet', 16)
('bridge', 6)
('concentration', 28)
('once', 42)
('mechanism', 8)
('potential', 15)
('analogs', 4)
('growth rate', 4)
('multiple', 2)
('flow cytometer', 4)
('molecule', 4)
('most', 2)
('enzymatic assay', 4)
('significant', 11)
('radioactive', 2)
('calculated', 4)
('tissue culture', 6)
('triphenylphosphine', 2)
('charged', 22)
('salt', 6)
('cox-2 inhibitors', 4)
('atmosphere', 2)
('5 hours', 4)
('evaporation', 2)
('spacer', 4)
('ic50', 50)
('analogue', 2)
('mice', 45)
('gastric gavage', 18)
('completion', 2)
('protein precipitation', 2)
('parameters', 2)
('colonic adenoma', 2)
('only', 16)
('carboxylate', 6)
('mortality', 2)
('continuity', 2)
('plate', 6)
('dependent', 15)
('overall', 2)
('caspase-dependent apoptosis', 2)
('preclinical', 2)
('pellet', 2)
('case reports', 2)
('substrate', 2)
('tunel', 10)
('approach', 8)
('tumors', 10)
('amide', 21)
('median', 10)
('pharmacokinetic studies', 14)
('twice', 12)
('cyclooxygenases', 1)
('common', 2)
('activity', 84)
('cleavage', 2)
('sensitivity', 2)
('testing', 8)
('observed', 6)
('culture', 18)
('ss amide', 3)
('result', 23)
('optimum', 4)
('inhibitory', 75)
('xenograft model', 6)
('chemical properties', 4)
('patients', 4)
('camptosar', 48)
('promega', 4)
('favor', 8)
('metabolites', 2)
('various', 4)
('60\\%', 12)
('tolerance', 10)
('ability', 16)
('oxidation', 2)
('wk', 6)
('modeling', 15)
('reaction', 4)
('improved', 2)
('region', 4)
('hours', 28)
('sensitive', 8)
('expression', 6)
('pdb', 2)
('nearby', 2)
('biological testing', 2)
('co', 674)
('animal studies', 2)
('dutp', 2)
('colon', 68)
('amine', 11)
('carbon', 4)
('table', 16)
('once daily', 6)
('forms', 6)
('addition', 16)
('strategy', 2)
('reduction', 12)
('basic', 4)
('ph', 44)
('efficacy', 17)
('drugs', 7)
('sufficient', 4)
('24 hours', 4)
('bioavailability', 4)
('arginine', 4)
('bulk', 2)
('suspension', 2)
('protocols', 2)
('case', 4)
('novel', 1)
('value', 53)
('lesser', 4)
('cages', 2)
('formalin', 2)
('identical', 4)
('crystal structure', 4)
('orientation', 4)
('cell growth', 56)
('topoisomerase inhibitor', 4)
('binding', 45)
('tumor cell', 87)
('tumorigenesis', 2)
('protein', 4)
('mouse', 11)
('regression', 2)
('media', 18)
('administration', 11)
('same', 4)
('complex', 4)
('modification', 11)
('plates', 6)
('sulfoxide', 24)
('events', 2)
('higher', 14)
('positive charge', 4)
('kit', 4)
('american type culture collection', 2)
('ion', 284)
('initial stage', 2)
('i-', 3)
('lower', 4)
('luminescence', 4)
('center', 4)
('prostaglandin synthesis', 5)
('changes', 4)
('epidemiologic studies', 2)
('well', 18)
('analysis', 6)
('materials', 1)
('position', 8)
('model', 44)
('subgroup', 4)
('sulindac', 77)
('protocol', 6)
('half', 12)
('rest', 6)
('dose', 16)
('50\\%', 2)
('human', 16)
('scintillation counter', 2)
('purified', 6)
('previous', 17)
('density', 8)
('affinity', 4)
('treatment', 126)
('extensive', 2)
('control group', 24)
('plasma', 31)
('sulindac sulfoxide', 12)
('cayman', 2)
('survival', 2)
('early', 6)
('possibly', 2)
('72 hours', 4)
('inhibition', 15)
('combined treatment', 7)
('55', 8)
('specific', 12)
('reduced', 12)
('therapeutic', 11)
('indications', 2)
('old', 14)
('methods', 1)
('apoptosis induction', 5)
('dose-dependent', 4)
('caliper', 2)
('growth', 99)
('amino group', 4)
('terminal deoxynucleotidyl transferase', 2)
('specified', 4)
('duration', 10)
('carboxylic acid', 18)
('plasma concentration', 2)
('2d', 4)
('dimensions', 2)
('bottom', 4)
('rofecoxib', 4)
('measurements', 4)
('ice', 59)
('epic', 2)
('cancer chemoprevention', 7)
('minimal', 2)
('schedule', 4)
('perpendicular', 2)
('substitution', 3)
('absorbance', 2)
('mmol', 2)
('manufacturer', 8)
('comparison', 16)
('nonpolar amino acids', 4)
('tumor', 192)
('plus', 14)
('concentrations', 24)
('mean', 26)
('block', 6)
('software', 6)
('guanidinium', 8)
('implantation', 6)
('ad libitum', 2)
('chronic', 2)
('2 days', 4)
('detectable', 6)
('\\/l', 60)
('utility', 1)
('van', 9)
('additional', 8)
('approximate', 12)
('clinical', 6)
('low', 22)
('cultures', 6)
('synthesis', 21)
('form', 20)
('70\\%', 6)
('neutral', 2)
('incorporation', 8)
('related', 2)
('automated', 2)
('sustained', 11)
('technologies', 2)
('default', 2)
('cells', 68)
('maximum', 18)
('vivo', 14)
('solvents', 2)
('mouse model', 7)
('polyps', 2)
('similar', 22)
('mtd', 10)
('chemoprevention', 10)
('deaths', 2)
('body weight loss', 6)
('strand', 14)
('evidence', 2)
('biochemical markers', 6)
('single', 12)
('amounts', 4)
('administered', 16)
('water', 4)
('role', 3)
('caspase activity', 4)
('deviation', 4)
('nsaid', 12)
('models', 4)
('important', 6)
('suppression', 13)
('caspases', 8)
('coupling', 2)
('sigma', 2)
('kinetics', 6)
('time course', 4)
('mass', 6)
('time', 26)
('4e', 4)
('4a', 4)


total: 540('chain', 2)
('ht-29', 36)
('lack', 21)
('resistance', 2)
('llc', 2)
('guava', 4)
('physiological', 4)
('graph', 4)
('body weights', 4)
('nu\\/nu', 6)
('tween', 14)
('suite', 2)
('activities', 16)
('assay', 34)
('apoptosis', 26)
('cyclooxygenase', 2)
('induce', 19)
('difference', 12)
('strand', 14)
('malignant disease', 3)
('entire', 2)
('kits', 2)
('2 hours', 4)
('unit density', 2)
('amine group', 8)
('smaller', 4)
('dna synthesis', 13)
('isozymes', 6)
('guidelines', 2)
('dish', 4)
('rate', 56)
('further', 6)
('acid', 26)
('caspase activation', 8)
('residue', 2)
('r120', 8)
('activity levels', 4)
('cell', 157)
('3h', 8)
('malignant cells', 2)
('3c', 4)
('3b', 4)
('increasing', 2)
('arachidonic acid', 2)
('injections', 8)
('proliferation', 4)
('colorectal cancer', 6)
('tumor cell lines', 5)
('iodine', 2)
('atoms', 4)
('thymidin', 12)
('groups', 14)
('106', 2)
('acceptor', 2)
('thymidine', 12)
('ellipsoid', 2)
('environment', 4)
('study', 12)
('larger', 2)
('tunel-positive', 2)
('reports', 4)
('example', 8)
('amount', 6)
('published', 4)
('action', 12)
('reagents', 4)
('toxicity', 5)
('studies', 55)
('highly', 8)
('ms\\/ms', 2)
('apc', 2)
('ammonium acetate', 2)
('total', 4)
('experimentation', 2)
('derivatives', 11)
('use', 45)
('amino acids', 6)
('dna', 29)
('cell proliferation', 2)
('positive', 26)
('isozyme', 8)
('molecular target', 4)
('vehicle', 14)
('oxidative metabolism', 4)
('stage', 8)
('more', 19)
('0\\%', 24)
('dosages', 10)
('line', 19)
('colon cancer', 5)
('ovine', 4)
('twice daily', 6)
('anti-inflammatory', 3)
('mg', 57)
('values', 31)
('male', 6)
('root', 4)
('dosage', 31)
('control', 38)
('tap', 2)
('indicated', 2)
('calculation', 4)
('epics', 2)
('agent', 8)
('sample', 8)
('sphere', 4)
('minimum', 2)
('tumorigenesis', 2)
('tunel assay', 2)
('monitoring', 2)
('discussion', 2)
('feature', 4)
('chemical', 16)
('methanol', 2)
('animal', 8)
('product', 2)
('atp', 6)
('specifications', 6)
('southern', 2)
('cox-1', 90)
('cox-2', 106)
('blood', 2)
('end', 21)
('data', 10)
('ss', 458)
('lines', 11)
('element', 2)
('nsaids', 10)
('representation', 2)
('proton magnetic resonance spectroscopy', 2)
('vehicle-treated', 8)
('experiments', 2)
('fetal bovine serum', 2)
('filters', 2)
('unfavorable', 4)
('group', 84)
('ligand', 8)
('fit', 16)
('pellet', 2)
('late', 30)
('condition', 8)
('derivative', 18)
('uptake', 2)
('non', 13)
('combination', 2)
('vitro', 25)
('break', 14)
('dock', 18)
('compound', 12)
('metabolite', 10)
('day', 68)
('structural', 4)
('alex', 2)
('oxygen', 4)
('l-', 5)
('labeling', 2)
('antineoplastic', 4)
('mode', 54)
('2b', 4)
('irinotecan hcl', 2)
('side', 12)
('mean', 26)
('heavy', 4)
('nick', 2)
('domain', 2)
('square', 4)
('weight', 50)
('series', 11)
('mas', 8)
('mm3', 4)
('intended', 2)
('\xc3\x97', 4)
('20\\%', 4)
('viability', 4)
('research', 2)
('increase', 20)
('mediated', 2)
('safety', 3)
('7', 91)
('formula', 6)
('induced', 12)
('induction', 9)
('viable', 2)
('molecular modeling', 8)
('solvent', 4)
('caspase', 32)
('standard', 4)
('formation', 4)
('propidium', 4)
('benefits', 8)
('xenograft', 9)
('days', 32)
('cell culture', 4)
('levels', 33)
('tumor growth', 25)
('coulter', 4)
('first', 4)
('size', 16)
('major', 8)
('xl', 2)
('number', 16)
('body weight', 16)
('electronic', 2)
('moiety', 21)
('maximum tolerated dose', 2)
('given', 10)
('t test', 10)
('top', 8)
('approximately', 8)
('sulfone', 18)
('intermediate', 2)
('observations', 6)
('chemotherapy', 5)
('percentage', 10)
('molecular', 12)
('structures', 14)
('final', 6)
('apoptotic', 12)
('ncr', 28)
('continuous', 8)
('antitumor', 17)
('part', 4)
('familial adenomatous polyposis', 4)
('institution', 4)
('center', 4)
('\\%\\ inhibition', 2)
('target', 8)
('fold', 8)
('preparation', 2)
('compensation', 2)
('chemically induced', 2)
('h 2', 4)
('treated', 22)
('time period', 8)
('bet', 16)
('cox-2\xe2\x80\x93overexpressing', 4)
('bridge', 6)
('half', 12)
('concentration', 28)
('once', 42)
('mechanism', 8)
('potential', 15)
('analogs', 4)
('growth rate', 4)
('multiple', 2)
('flow cytometer', 4)
('molecule', 4)
('most', 2)
('enzymatic assay', 4)
('significant', 11)
('radioactive', 2)
('calculated', 4)
('flow', 4)
('tissue culture', 6)
('triphenylphosphine', 2)
('subgroup', 4)
('sigma', 2)
('cox-2 inhibitors', 4)
('atmosphere', 2)
('5 hours', 4)
('evaporation', 2)
('spacer', 4)
('ic50', 50)
('malignant', 5)
('analogue', 2)
('technologies', 2)
('gastric gavage', 18)
('completion', 2)
('protein precipitation', 2)
('parameters', 2)
('3', 127)
('colonic adenoma', 2)
('terminal', 2)
('only', 16)
('carboxylate', 6)
('mortality', 2)
('continuity', 2)
('plate', 6)
('dependent', 15)
('overall', 2)
('caspase-dependent apoptosis', 2)
('2', 344)
('preclinical', 2)
('ssa', 259)
('case reports', 2)
('substrate', 2)
('tunel', 10)
('approach', 8)
('tumors', 10)
('amide', 21)
('median', 10)
('pharmacokinetic studies', 14)
('twice', 12)
('cyclooxygenases', 1)
('common', 2)
('activity', 84)
('cleavage', 2)
('sensitivity', 2)
('testing', 8)
('observed', 6)
('culture', 18)
('ss amide', 3)
('result', 23)
('optimum', 4)
('inhibitory', 75)
('xenograft model', 6)
('chemical properties', 4)
('patients', 4)
('camptosar', 48)
('promega', 4)
('favor', 8)
('metabolites', 2)
('various', 4)
('60\\%', 12)
('tolerance', 10)
('ability', 16)
('oxidation', 2)
('cox\\-2\\.', 8)
('wk', 6)
('fig\\.', 68)
('modeling', 15)
('reaction', 4)
('improved', 2)
('1640', 2)
('cox', 240)
('region', 4)
('beckman', 2)
('sensitive', 8)
('expression', 6)
('pdb', 2)
('nearby', 2)
('and', 389)
('co', 674)
('animal studies', 2)
('dutp', 2)
('transferase-mediated', 2)
('amine', 11)
('carbon', 4)
('table', 16)
('once daily', 6)
('forms', 6)
('addition', 16)
('strategy', 2)
('reduction', 12)
('basic', 4)
('ph', 44)
('fig', 68)
('efficacy', 17)
('drugs', 7)
('sufficient', 4)
('24 hours', 4)
('bioavailability', 4)
('arginine', 4)
('bulk', 2)
('suspension', 2)
('protocols', 2)
('case', 4)
('novel', 1)
('value', 53)
('rpmi', 2)
('cages', 2)
('formalin', 2)
('identical', 4)
('crystal structure', 4)
('orientation', 4)
('topoisomerase', 4)
('cell growth', 56)
('topoisomerase inhibitor', 4)
('binding', 45)
('tumor cell', 87)
('deoxynucleotidyl', 2)
('protein', 4)
('mouse', 11)
('regression', 2)
('media', 18)
('administration', 11)
('same', 4)
('complex', 4)
('modification', 11)
('plates', 6)
('sulfoxide', 24)
('events', 2)
('higher', 14)
('cytometer\\.', 4)
('positive charge', 4)
('kit', 4)
('american type culture collection', 2)
('ion', 284)
('initial stage', 2)
('i-', 3)
('two', 6)
('sulindac sulfone', 4)
('lower', 4)
('luminescence', 4)
('in vitro', 23)
('prostaglandin synthesis', 5)
('changes', 4)
('epidemiologic studies', 2)
('well', 18)
('analysis', 6)
('materials', 1)
('position', 8)
('model', 44)
('dosing\\.', 2)
('charged', 22)
('sulindac', 77)
('protocol', 6)
('lesser', 4)
('biological testing', 2)
('docking', 8)
('carboxylic', 18)
('rest', 6)
('dose', 16)
('50\\%', 2)
('human', 16)
('scintillation counter', 2)
('purified', 6)
('previous', 17)
('density', 8)
('affinity', 4)
('treatment', 126)
('\\.', 666)
('extensive', 2)
('control group', 24)
('plasma', 31)
('\\(', 121)
('\\)', 121)
('sulindac sulfoxide', 12)
('cayman', 2)
('survival', 2)
('early', 6)
('possibly', 2)
('72 hours', 4)
('inhibition', 15)
('using', 70)
('combined treatment', 7)
('hours', 28)
('55', 8)
('specific', 12)
('colon', 68)
('reduced', 12)
('therapeutic', 11)
('indications', 2)
('old', 14)
('methods', 1)
('apoptosis induction', 5)
('dose-dependent', 4)
('caliper', 2)
('growth', 99)
('amino group', 4)
('terminal deoxynucleotidyl transferase', 2)
('specified', 4)
('duration', 10)
('carboxylic acid', 18)
('plasma concentration', 2)
('2d', 4)
('caspases', 8)
('bottom', 4)
('rofecoxib', 4)
('measurements', 4)
('ice', 59)
('fragments', 6)
('epic', 2)
('cancer chemoprevention', 7)
('minimal', 2)
('schedule', 4)
('perpendicular', 2)
('substitution', 3)
('absorbance', 2)
('mmol', 2)
('manufacturer', 8)
('comparison', 16)
('nonpolar amino acids', 4)
('tumor', 192)
('plus', 14)
('concentrations', 24)
('investigators', 10)
('block', 6)
('software', 6)
('guanidinium', 8)
('implantation', 6)
('ad libitum', 2)
('chronic', 2)
('2 days', 4)
('detectable', 6)
('\\/l', 60)
('utility', 1)
('van', 9)
('additional', 8)
('approximate', 12)
('clinical', 6)
('low', 22)
('cultures', 6)
('synthesis', 21)
('form', 20)
('70\\%', 6)
('neutral', 2)
('incorporation', 8)
('related', 2)
('automated', 2)
('sustained', 11)
('mice', 45)
('default', 2)
('cells', 68)
('maximum', 18)
('vivo', 14)
('solvents', 2)
('mouse model', 7)
('polyps', 2)
('similar', 22)
('mtd', 10)
('chemoprevention', 10)
('deaths', 2)
('body weight loss', 6)
('evidence', 2)
('biochemical markers', 6)
('single', 12)
('amounts', 4)
('administered', 16)
('water', 4)
('hct116', 9)
('role', 3)
('mass', 6)
('caspase activity', 4)
('deviation', 4)
('nsaid', 12)
('models', 4)
('important', 6)
('suppression', 13)
('dimensions', 2)
('coupling', 2)
('salt', 6)
('kinetics', 6)
('time course', 4)
('sw480', 11)
('assay\\.', 4)
('time', 26)
('4e', 4)
('4b', 4)
('4a', 4)
